About 500 reports

Major companies in the respiratory diseases market include Boehringer Ingelheim GmbH, Vertex Pharmaceuticals, AstraZeneca, Pfizer Inc., GlaxosmithKline, Novartis AG, Johnson & Johnson, Reckitt Benckiser Group plc., Mylan N.V. and Sanofi S.A. The global respiratory diseases drugs market is expected to grow from $142.57 billion in 2021...

  • Respiratory Disease
  • Europe
  • World
  • Western Europe
  • South America
  • Middle East
  • United States
  • APAC

Respiratory Disease Testing market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Respiratory Disease Testing Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Respiratory Disease Testing types, applications....

  • Respiratory Disease
  • World

Bovine Respiratory Disease Treatment market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Bovine Respiratory Disease Treatment Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Bovine Respiratory Disease...

  • Respiratory Disease
  • World

Pediatric Respiratory Disease Therapeutics market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Pediatric Respiratory Disease Therapeutics Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Pediatric Respiratory...

  • Respiratory Disease
  • Therapy
  • World

Major companies in the respiratory diseases drugs market include GlaxosmithKline Plc; AstraZeneca Plc; Merck & Co; Novartis AG and Johnson & Johnson. The global respiratory diseases drugs market is expected to decline from $90.32 billion in 2020 to $79.82 billion in 2021 at a compound annual growth rate (CAGR) of -11.6%. The change...

  • Respiratory Disease
  • World

Bovine Respiratory Disease Treatment Market Report Overview Bovine Respiratory Disease Treatment market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Bovine Respiratory Disease Treatment market types and applications. It is a focused study...

  • Respiratory Disease
  • World
  • Health Provider Density

Pediatric Respiratory Disease Therapeutics Market Report Overview Pediatric Respiratory Disease Therapeutics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Pediatric Respiratory Disease Therapeutics market types and applications. It...

  • Respiratory Disease
  • World
  • Health Provider Density

Respiratory Disease Testing Market Report Overview Respiratory Disease Testing market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Respiratory Disease Testing market types and applications. It is a focused study on Respiratory Disease Testing...

  • Respiratory Disease
  • World
  • Health Provider Density

Abstract: - Global Bovine Respiratory Disease Treatment Market to Reach $1.6 Billion by 2027 - Amid the COVID-19 crisis, the global market for Bovine Respiratory Disease Treatment estimated at US$1 Billion in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at a CAGR of 6.4% over...

  • Respiratory Disease
  • World
  • China
  • United States

Abstract: - Global Respiratory Disease Testing Market to Reach $3.3 Billion by 2027 - Amid the COVID-19 crisis, the global market for Respiratory Disease Testing estimated at US$2.8 Billion in the year 2020, is projected to reach a revised size of US$3.3 Billion by 2027, growing at a CAGR of 2.2% over the analysis...

  • Respiratory Disease
  • Point Of Care Testing
  • World
  • China
  • United States

Executive Summary Global Ventilator Market was valued at USD 1198.54 Million in the year 2019. Escalating number of cases related to Respiratory and Lungs Diseases with growing prevalence of COPD, Strokes supported by ever growing geriatric population and companies investing heavily in incorporating advanced technology...

  • Respiratory Disease
  • Stroke
  • World
  • APAC
  • Chronic Obstructive Pulmonary Disease Prevalence
  • Health Expenditure

Respiratory diseases are related to the airways and the structures of the lungs. They can affect air sacs, interstitium, blood vessels, pleura, and chest wall. Common respiratory diseases include chronic obstructive pulmonary disease (COPD), asthma, pulmonary hypertension, and occupational lung disease.According to the World Health...

  • Respiratory Disease
  • World

Respiratory Disease Testing Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Respiratory Disease Testing market including the COVID-19 pandemic...

  • Respiratory Disease
  • APAC
  • Central America

Abstract: - Global Medical Microbiology Testing Technologies Market to Reach $3.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Medical Microbiology Testing Technologies estimated at US$2.5 Billion in the year 2020, is projected to reach a revised size of US$3.2 Billion by 2027, growing at a CAGR...

  • Infectious Disease
  • Clinical Microbiology Testing
  • Respiratory Disease
  • Neurological Disorder
  • World
  • China
  • United States

This report is 80% complete and can be delivered within three working days post order confirmation and will include the latest impact analysis of Covid-19 in 2020 and forecast. Global Respiratory Disease Testing Market By Product and Service (Instruments & Devices, Assays & Reagents, Services & Software), By Test Type...

  • Respiratory Disease
  • World

Global Respiratory Disease Testing Market 2021-2025 The analyst has been monitoring the respiratory disease testing market and it is poised to grow by USD 3.52 bn during 2021-2025, progressing at a CAGR of 7.01% during the forecast period. Our report on the respiratory disease testing market provides a holistic analysis,...

  • Respiratory Disease
  • World
  • Chronic Obstructive Pulmonary Disease Prevalence

Global Continuous Positive Airway Pressure Market to Reach $10,182.0 Million by 2026 Market Report Coverage - Continuous Positive Airway Pressure (CPAP) Market Segmentation • End User (Hospitals and Clinics, Nursing Homes, Elderly Care Centers, and Home-Use) Regional Segmentation •...

  • Medical Ventilator
  • Respiratory Disease
  • World

2021 Global Respiratory Diseases Diagnostic Testing Market Assessment--US, Europe, Japan--Competitive Shares and SWOT Analysis, Volume and Sales Segment Forecasts--Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers This new 366-page report contains 108 tables and provides...

  • Respiratory Disease
  • Diagnostics
  • World
  • Europe

2021 Global Respiratory Diseases Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers This unique report provides information and analysis not available from any other published source.The report is available...

  • Respiratory Disease
  • World
  • Europe
  • Japan
  • United States

2021 Europe Respiratory Diseases Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers This unique report provides information and analysis not available from any other published source.The report is available...

  • Respiratory Disease
  • Europe

Major players in the ventilator devices market are Philips Healthcare, ResMed, Medtronic, Becton, Dickinson and Company, GE Healthcare, Hamilton Medical, Dräger, Getinge, Smiths Group, and Fisher & Paykel. The global ventilators market is expected to decline from $12.11 billion in 2020 to $3.46 billion in 2021 at a compound annual growth...

  • Infectious Disease
  • Respiratory Disease
  • World

Capnography Devices Market The global market for capnography devices is set to increase to $736.6 million by 2030 from $422.1 million in 2020, at a 5.7% CAGR between 2020 and 2030, according to the market research report published . The following are the major driving factors for...

  • Respiratory Monitoring
  • Respiratory Disease
  • World
  • United States

Endotracheal Tube Market Size, Share & Trends Analysis Report By Product Type (Regular Endotracheal Tube, Reinforced Endotracheal Tube), By Route Type, By Application, By End-use, By Region, And Segment Forecasts, 2021 - 2028 Endotracheal Tube Market Growth & Trends The global endotracheal...

  • Chronic Disease
  • Respiratory Disease
  • World
  • APAC
  • Chronic Disease Prevalence
  • Smoking Prevalence

Spirometer Market by Type (Hand-Held and Table-Top), Technology (Volume Measurement and Flow Measurement), Application (Asthma, COPD and others), and End User (Hospitals and Clinics, Home Healthcare and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027 The global spirometer market accounted for $1,079.51...

  • Respiratory Monitoring
  • Respiratory Disease
  • World

Smart Inhalers: Market Size From $86.17 million in 2020, the global Smart Inhalers market is projected to reach $3,213.55 million by 2028. Based on our analysis the market is expected to grow at a CAGR of 57.2% from 2020 - 2028 timeframe. Some of the prominent trends that the market is witnessing include increased...

  • Respiratory Disease
  • World
  • APAC
  • Chronic Obstructive Pulmonary Disease Prevalence

The global nebulizers market reached a value of US$ 1.67 Billion in 2020. Looking forward, the analyst expects the market to grow at a CAGR of around 7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use...

  • Respiratory Device
  • Respiratory Disease
  • World
  • Overweight Prevalence
  • Tobacco Consumption

Respiratory diseases are on the rise globally due to various factors, including environmental ones.Obstructive lung diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis are a huge burden on the global healthcare system. Existing therapies can only reduce the impact and provide short-term relief,...

  • Respiratory Disease
  • Therapy
  • World

Aerosol Delivery Devices Market by Product (Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), and Nebulizers), Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, and Non-Respiratory Diseases), and Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and E-commerce): Global Opportunity...

  • Pulmonary Delivery
  • Respiratory Device
  • Respiratory Disease
  • World
  • APAC
  • Asthma Prevalence

KEY FINDINGS The global cough syrup market is anticipated to develop with a CAGR of 2.87% over the forecasting years of 2021 to 2028. The market growth is mainly ascribed to chief factors such as the increasing geriatric population as well as the surging incidence of chronic respiratory conditions. MARKET...

  • Cough And Cold
  • Respiratory Disease
  • World
  • Smoking Prevalence
  • Energy Consumption

Aerosol Market Size, Share & Trends Analysis Report By Material (Steel, Aluminum), By Type (Bag-In-Valve, Standard), By Application (Personal Care, Household), By Region (EU, APAC), And Segment Forecasts, 2022 - 2030 Aerosol Market Growth & Trends The global aerosol market size is anticipated...

  • Personal Care
  • Respiratory Disease
  • World
  • APAC